Cargando…

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)

BACKGROUND: This European multicenter study aimed to elucidate suicidality in major depressive disorder. Previous surveys suggest a prevalence of suicidality in major depressive disorder of ≥50%, but little is known about the association of different degrees of suicidality with socio-demographic, ps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dold, Markus, Bartova, Lucie, Fugger, Gernot, Kautzky, Alexander, Souery, Daniel, Mendlewicz, Julien, Papadimitriou, George N, Dikeos, Dimitris, Ferentinos, Panagiotis, Porcelli, Stefano, Serretti, Alessandro, Zohar, Joseph, Montgomery, Stuart, Kasper, Siegfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007240/ https://www.ncbi.nlm.nih.gov/pubmed/29860382 http://dx.doi.org/10.1093/ijnp/pyy009

Ejemplares similares

Age as a moderating factor of treatment resistance in depression
por: Kautzky, Alexander, et al.
Publicado: (2023)

Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database
por: Kraus, Christoph, et al.
Publicado: (2023)

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers
por: Bartova, Lucie, et al.
Publicado: (2016)

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
por: Dold, M., et al.
Publicado: (2018)

The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
por: Bartova, Lucie, et al.
Publicado: (2021)

Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
por: Fugger, Gernot, et al.
Publicado: (2020)

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
por: Fugger, Gernot, et al.
Publicado: (2022)

Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression
por: Bartova, Lucie, et al.
Publicado: (2021)

Psychotherapy employed additionally to Psychopharmacotherapy is not related to Better Treatment Outcome in Major Depressive Disorder
por: Bartova, L., et al.
Publicado: (2022)

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
por: Kautzky, A., et al.
Publicado: (2018)

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping
por: Fabbri, Chiara, et al.
Publicado: (2020)

PS87. An update on prediction of treatment outcome in treatment resistant depression
por: Kautzky, Alexander, et al.
Publicado: (2016)

Silexan for treatment of anxiety and depression in the context of COVID-19
por: Bartova, Lucie, et al.
Publicado: (2023)

The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives
por: Fabbri, Chiara, et al.
Publicado: (2018)

Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample
por: Zaninotto, Leonardo, et al.
Publicado: (2015)

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study
por: Schosser, Alexandra, et al.
Publicado: (2017)

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment
por: Dold, Markus, et al.
Publicado: (2020)

Polygenic risk scores for neuropsychiatric, inflammatory, and cardio‐metabolic traits highlight possible genetic overlap with suicide attempt and treatment‐emergent suicidal ideation
por: Fanelli, Giuseppe, et al.
Publicado: (2022)

Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
por: Bartova, Lucie, et al.
Publicado: (2022)

Combining machine learning algorithms for prediction of antidepressant treatment response
por: Kautzky, Alexander, et al.
Publicado: (2020)

Silexan for treatment of psychiatric manifestations in the context of COVID-19: a case series
por: Bartova, L., et al.
Publicado: (2023)

Towards achieving remission in the treatment of depression
por: Mendlewicz, Julien
Publicado: (2008)

Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
por: Dold, Markus, et al.
Publicado: (2023)

Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: case report
por: Theleritis, Christos G, et al.
Publicado: (2006)

Mechanische Schutzfixierung – Herausforderungen und Management: Fallvignetten aus der psychiatrischen Intermediate Care Station der Wiener Universitätsklinik
por: Popper, Valentin, et al.
Publicado: (2021)

Anhedonia and Depressive Disorders
por: Serretti, Alessandro
Publicado: (2023)

Driving Behaviour in Depression Based on Subjective Evaluation and Data from a Driving Simulator
por: Tsoutsi, Vagioula, et al.
Publicado: (2023)

Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment
por: Fabbri, Chiara, et al.
Publicado: (2020)

Abelson Helper Integration Site-1 Gene Variants on Major Depressive Disorder and Bipolar Disorder
por: Porcelli, Stefano, et al.
Publicado: (2014)

Clinical Utility of Fluid Biomarker in Depressive Disorder
por: Serretti, Alessandro
Publicado: (2022)

Familiality and SNP heritability of age at onset and episodicity in major depressive disorder
por: Ferentinos, P., et al.
Publicado: (2015)

Interleukin-1 Beta in Peripheral Blood Mononuclear Cell Lysates as a Longitudinal Biomarker of Response to Antidepressants: A Pilot Study
por: Ferentinos, Panagiotis, et al.
Publicado: (2021)

Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study
por: Meyer, Bernhard M., et al.
Publicado: (2019)

Editorial for Treatment-Resistant Depression (TRD)
por: Kasper, Siegfried, et al.
Publicado: (2019)

Pattern of inpatient care for depression: an analysis of 232,289 admissions
por: Fugger, Gernot, et al.
Publicado: (2020)

Possible Modulatory Role of ARC Gene Variants in Mood Disorders
por: Crisafulli, Concetta, et al.
Publicado: (2021)

Pharmacogenetics and Depression: A Critical Perspective
por: Corponi, Filippo, et al.
Publicado: (2019)

Subjective and Objective Evaluation of Driving Behaviour in Depression
por: Tsoutsi, V, et al.
Publicado: (2023)

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
por: Fabbri, Chiara, et al.
Publicado: (2020)

A New Characterization of Mental Health Disorders Using Digital Behavioral Data: Evidence from Major Depressive Disorder
por: Taliaz, Dekel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_38vpm58qjsjt1rt6nqlqn9jand